Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McCall

Showing results (481-490 of 501) with videos related to

Pageof 51
Sort By:
Lung Cancer (Amsterdam, Netherlands)|January 19, 2021
RNA splicing and aggregate gene expression differences in lung squamous cell carcinoma between patients of West African and European ancestryApril E Deveaux, Tyler A Allen, Muthana Al Abo, et al.
Clinical Genitourinary Cancer|April 23, 2024
Treatment Patterns and Clinical Outcomes Among Patients With Metastatic Prostate Cancer Harboring Homologous Recombination Repair MutationsPriyanka J Bobbili, Jasmina Ivanova, David B Solit, et al.
Annals of Emergency Medicine|July 27, 2001
The model of the clinical practice of emergency medicineR S Hockberger, L S Binder, M A Graber, et al.
Cancers|November 14, 2020
A Comparative Oncology Drug Discovery Pipeline to Identify and Validate New Treatments for OsteosarcomaJason A Somarelli, Gabrielle Rupprecht, Erdem Altunel, et al.
Science Translational Medicine|December 16, 2016
PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translationGray R Anderson, Suzanne E Wardell, Merve Cakir, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2014
Time-varying, serotype-specific force of infection of dengue virusRobert C Reiner, Steven T Stoddard, Brett M Forshey, et al.
Cell Reports|July 27, 2017
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor EvolutionGrace R Anderson, Peter S Winter, Kevin H Lin, et al.
The Lancet. Oncology|February 17, 2015
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 studyAlison J Moskowitz, Heiko Schöder, Joachim Yahalom, et al.
Cell Reports|December 7, 2017
Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary ConvergenceKatherine R Singleton, Lorin Crawford, Elizabeth Tsui, et al.
NPJ Precision Oncology|May 31, 2024
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancersDaniel P Nussbaum, Colin A Martz, Andrew M Waters, et al.
Pageof 51

Showing results (481-490 of 501) with videos related to

Sort By:
Pageof 51
Lung Cancer (Amsterdam, Netherlands)|January 19, 2021
RNA splicing and aggregate gene expression differences in lung squamous cell carcinoma between patients of West African and European ancestryApril E Deveaux, Tyler A Allen, Muthana Al Abo, et al.
Clinical Genitourinary Cancer|April 23, 2024
Treatment Patterns and Clinical Outcomes Among Patients With Metastatic Prostate Cancer Harboring Homologous Recombination Repair MutationsPriyanka J Bobbili, Jasmina Ivanova, David B Solit, et al.
Annals of Emergency Medicine|July 27, 2001
The model of the clinical practice of emergency medicineR S Hockberger, L S Binder, M A Graber, et al.
Cancers|November 14, 2020
A Comparative Oncology Drug Discovery Pipeline to Identify and Validate New Treatments for OsteosarcomaJason A Somarelli, Gabrielle Rupprecht, Erdem Altunel, et al.
Science Translational Medicine|December 16, 2016
PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translationGray R Anderson, Suzanne E Wardell, Merve Cakir, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2014
Time-varying, serotype-specific force of infection of dengue virusRobert C Reiner, Steven T Stoddard, Brett M Forshey, et al.
Cell Reports|July 27, 2017
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor EvolutionGrace R Anderson, Peter S Winter, Kevin H Lin, et al.
The Lancet. Oncology|February 17, 2015
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 studyAlison J Moskowitz, Heiko Schöder, Joachim Yahalom, et al.
Cell Reports|December 7, 2017
Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary ConvergenceKatherine R Singleton, Lorin Crawford, Elizabeth Tsui, et al.
NPJ Precision Oncology|May 31, 2024
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancersDaniel P Nussbaum, Colin A Martz, Andrew M Waters, et al.
Pageof 51